PIK3CA and head and neck squamous cell carcinoma: In retrospect, these disappointing clinical studies may have been predicted by preclinical studies that demonstrated that although PIK3CA-mutant HNSCC cell lines are more sensitive to PI3K inhibitors than PIK3CA-wt HNSCC cell lines [62,63], PI3K inhibition leads only to growth arrest, not cell death [85].